CD63<sup>+</sup> Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22
2020 · Advanced Science · 141 citations
https://doi.org/10.1002/advs.202002518
C
Cheng Zeng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
933
Citations
16
h-index
21
i10-index
Cheng Zeng is an academic researcher from Zhejiang International Studies University. The author has contributed to research in topics: Organ Transplantation Techniques and Outcomes & Liver Disease and Transplantation & Cancer-related molecular mechanisms research. The author has an h-index of 16, co-authored 44 publications.
ORCID: 0000-0002-7327-7807Papers by this author
worksFOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
2018 · Cell Death and Disease · 59 citations
https://doi.org/10.1038/s41419-018-0790-8
Laminins in tumor-derived exosomes upregulated by ETS1 reprogram omental macrophages to promote omental metastasis of ovarian cancer
2022 · Cell Death and Disease · 44 citations
https://doi.org/10.1038/s41419-022-05472-7
Bufalin-Loaded PEGylated Liposomes: Antitumor Efficacy, Acute Toxicity, and Tissue Distribution
2019 · Nanoscale Research Letters · 26 citations
https://doi.org/10.1186/s11671-019-3057-0
ANKRD29, as a new prognostic and immunological biomarker of non–small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway
2023 · Biology Direct · 7 citations
https://doi.org/10.1186/s13062-023-00385-7
Microalgae-based biodegradable embolic agent for the treatment of hepatocellular carcinoma through transarterial embolization
2025 · Journal of Nanobiotechnology · 5 citations
https://doi.org/10.1186/s12951-025-03290-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat